Welcome to our dedicated page for CABOT SEC filings (Ticker: CBT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CABOT's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CABOT's regulatory disclosures and financial reporting.
Cabot Corporation (CBT) notice reports a proposed sale of 114,436 common shares, with an aggregate market value of $9,072,097.22, to be sold on 08/14/2025 through Fidelity Brokerage Services (NYSE). The filing shows the shares were acquired by exercise of options originally granted on 03/21/2016 (26,455 shares) and 11/11/2016 (87,981 shares) and that payment will be in cash. The filer states no securities of the issuer were sold by the same person in the past three months and attests they are not aware of undisclosed material adverse information about the issuer.